跳至主要内容
临床试验/JPRN-UMIN000017647
JPRN-UMIN000017647已完成未知

Efficacy of duloxetine for cancer patients with neuropathic pain: Doubleblind, Randomized, Placebo controlled, exploratory trial - Efficacy of duloxetine for cancer patients with neuropathic pain: Doubleblind, Randomized, Placebo controlled, exploratory trial

Japan Agency for Medical Research and Development0 个研究点目标入组 80 人开始时间: 2015年5月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Chemotherapy-induced Peripheral Neuropathy 2) Progressive paralysis 3) Allergy to duloxetine 4) Depression 5) Patients who changed analgesic adjuvant agents within 2 days 6) Drug dependence or abuse 7) Uncontrolled psychiatric disease 8) Pregnancy or lactating patients 9) Patients who are judged as inadequate to participate to the trial due to other reasons by the doctor.

研究者

相似试验